Pixilab
Home › Companies › SEC Form D - Biotechnology › Arcellx, Inc.

Arcellx, Inc.

SEC Form D private-offering issuer in Biotechnology

Based based in GERMANTOWN, MARYLAND, Arcellx, Inc. works in sec form d - biotechnology, founded in 2014.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2019Q3. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 83681224.

Within the sec form d - biotechnology space, the company focuses on its core offering rather than a broad product line.

The business is associated with GERMANTOWN, MARYLAND.

The company is listed at the Regulation D stage of development.

The company reports a headcount in the 1-10 range.

Public records show total funding of about $83.7M.

SectorSEC Form D - Biotechnology
HeadquartersGERMANTOWN, MARYLAND
CountryUnited States
Founded2014
Employees1-10
StageRegulation D
Total funding$83,681,224

Website: encartatx.com

Browse related

More SEC Form D - Biotechnology companies Companies in United States Companies founded in 2014
Emails and contact routes are reserved for registered members.
Create a free account